Viewing Study NCT05453903


Ignite Creation Date: 2025-12-24 @ 7:13 PM
Ignite Modification Date: 2026-04-20 @ 4:56 PM
Study NCT ID: NCT05453903
Status: RECRUITING
Last Update Posted: 2025-12-24
First Post: 2022-07-08
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: A Study of Bleximenib in Combination With Acute Myeloid Leukemia (AML) Directed Therapies
Sponsor: Janssen Research & Development, LLC
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module